Table 2.
IC50, IDV, relative change in IC50 compared to NL4-3 susceptibility
| IC50 nM | WT | NL4-3-S40A | NL4-3-S40F | NL4-3 multi-drug resistant strain |
|---|---|---|---|---|
| Expt 1 | 1.0 | 0.94 | 1.0 | 20.0 |
| Expt 2 | 1.0 | 0.70 | 0.90 | 22.6 |
IC50, IDV, relative change in IC50 compared to NL4-3 susceptibility
| IC50 nM | WT | NL4-3-S40A | NL4-3-S40F | NL4-3 multi-drug resistant strain |
|---|---|---|---|---|
| Expt 1 | 1.0 | 0.94 | 1.0 | 20.0 |
| Expt 2 | 1.0 | 0.70 | 0.90 | 22.6 |